RTW Venture Fund, Ltd.

RTW Venture Fund, Ltd. is an investment fund focused on identifying transformative assets with growth potential across the life sciences sector

Our approach is driven by applying deep scientific expertise with a long-term investment horizon. The Company is managed by RTW Investments, LP a life sciences investment and innovation firm. 

RTW financial highlights

As of 28 February 2023

$334.6M

Ordinary NAV

$1.58

NAV per Ordinary Share

$1.28

Ordinary share price

$271.9M

Market cap

51.5%

Ordinary NAV per share growth since admission

22.6%

Total shareholder return since admission

Artiva White C4 White Dermtech White Encoded Therapeutics White Established Labs White Jixing White Stoke Therapeutics White Tarsus White

Our investments

We are full life cycle investors supporting scientists and entrepreneurs at any stage where we identify opportunity, from academic programs in need of industry sponsorship all the way to mature publicly traded companies.

Also in this section

RTWF
1.03 USD
Change -0.03 (-3.21%)
Last updated on Mar 31, 2023 19:00

Share Price

We connect data, experience and skills to bring hidden opportunities into focus. 

Board of Directors

The board consists of a group of highly experienced professionals and business experts with a deep understanding of the dynamics of the industry at both a local and international level.

Key information

Portfolio manager RTW Investments, LP
Shareholder contact [email protected]
Admission date 30 October 2019
Year end 31 October
Results announces Late March / early April
Next AGM June
Management fee 1.25%
Performance fee 20% over 8% hurdle with catchup
Dividend policy  The company does not anticipate paying a dividend
Listing London Stock Exchange (Premium Listing)
SEDOL BKTRRM2; BNNXVW5
ISIN GG00BKTRRM22
Bloomberg ticker RTW LN; RTWG LN
Currency USD; GBP
Reporting currency USD
Company secretary Elysium
Administrator MSFS
Corporate Brokers JP Morgan Cazenove; BofA Securities
Public Relations Buchanan
Registrars Link Asset Managers
Custodians  Barclays; Goldman Sachs
Prime brokers Goldman Sachs
Auditor KPMG

This website is not intended to offer or to promote the offer or sale of the shares (the “shares”) of RTW Venture Fund Limited (the “company”) in the United States or to any “U.S. persons” as defined in regulation s (“US persons”) under the US Securities Act of 1933, as amended (the “securities act”). The materials contained herein are not for release, publication or distribution, directly or indirectly, in whole or in part, to any persons to whom or into or within any jurisdiction where to do so would constitute a violation of applicable law or regulation.

The information contained herein and on the pages that follow does not constitute or form a part of any offer to sell or issue, or the solicitation of any offer to purchase, subscribe for or otherwise acquire, any securities in the United States or in any jurisdiction in which, or to any person to whom, such an offer or solicitation would be unlawful.

The Company has not been and will not be registered under the US Investment Company Act of 1940, as amended (the “Investment Company Act”), and as such holders of the Shares are not and will not be entitled to the benefits of the Investment Company Act. The Shares have not been and will not be registered under the Securities Act, or with any securities regulatory authority of any state or other jurisdiction of the United States, and may not be offered, sold, resold, pledged, delivered, assigned or otherwise transferred, directly or indirectly, into or within the United States or to, or for the account or benefit of, any US Persons, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States and in a manner which would not result in the Company being required to register under the Investment Company Act. There has been and will be no public offer of the Shares in the United States. The offer and sale of the Shares have not been and will not be registered under the applicable securities laws of Australia, Canada, Japan or South Africa. Potential users of the information contained herein and on the pages that follow are requested to inform themselves about and to observe all applicable restrictions.

The information contained herein and on the pages that follow may contain forward-looking statements. Any statement other than a statement of historical fact is a forward-looking statement. Actual results may differ materially from those expressed or implied by any forward-looking statement. The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. You should not place undue reliance on any forward-looking statement, which speaks only as of the date of its issuance. The Company may change these terms and conditions from time to time and any such changes will be posted on this website. Your access to this website is governed by the version of these terms and conditions then in force.

By clicking “Agree” below, you represent, warrant, undertake and agree that (1) you have read, understood and agree to be bound by the terms and conditions and other information set out herein, (2) you are permitted under applicable laws and regulations to receive the information contained herein and on the pages that follow, (3) you are either (a) located outside the United States and are not a US Person or (b) an existing shareholder of the Company who is a “qualified purchaser” as defined under the Investment Company Act and (4) you will not further transmit or send any information contained in this website to any other persons in the United States or who are US Persons or to any publications with a general circulation in the United States. If you cannot so represent, warrant, undertake and agree, you must click the button labelled “Decline” or otherwise exit this website.